The United States has struck a deal with Pfizer to pay the pharmaceutical giant almost $2 billion for 3.7 million more courses of Paxlovid.
“The additional 3.7 million treatment courses are planned for delivery by early 2023,” the company announced.
The Defense Department announced on Dec. 13 that Pfizer was awarded a $1,959,999,848 contract for Paxlovid. “Work will be performed in New York, New York, with an estimated completion date of Dec. 31, 2028,” according to the Pentagon.
“Fiscal 2021 Coronavirus Preparedness Response and Relief Supplemental Appropriations Act funds in the amount of $1,959,999,848 were obligated at the time of the award. U.S. Army Contracting Command, New Jersey, is the contracting activity,” the announcement reads….